blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4111202

EP4111202 - METHODS OF TREATING CANCER [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  02.12.2022
Database last updated on 24.08.2024
FormerThe international publication has been made
Status updated on  03.09.2021
Most recent event   Tooltip06.06.2024Supplementary search reportpublished on 03.07.2024  [2024/27]
Applicant(s)For all designated states
The Broad Institute Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, Massachusetts 02215 / US
[2023/01]
Inventor(s)01 / GOLUB, Todd, R.
c/o The Broad Institute, Inc.
415 Main Street
Cambridge, Massachusetts 02142 / US
02 / TSVETKOV, Peter
c/o The Broad Institute, Inc.
415 Main Street
Cambridge, MA 02142 / US
 [2023/01]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2023/01]
Application number, filing date21759702.026.02.2021
[2023/01]
WO2021US19871
Priority number, dateUS202062983300P28.02.2020         Original published format: US 202062983300 P
[2023/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021173970
Date:02.09.2021
Language:EN
[2021/35]
Type: A1 Application with search report 
No.:EP4111202
Date:04.01.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.2021 takes the place of the publication of the European patent application.
[2023/01]
Search report(s)International search report - published on:IL02.09.2021
(Supplementary) European search report - dispatched on:EP05.06.2024
ClassificationIPC:A61K31/165, A61P35/00, G01N33/574, A61K31/30, A61K31/7135, A61K31/7068, A61K31/555, A61K31/145, A61K45/06, A61K31/5377, A61K31/337, A61K31/4427, A61K31/47, A61K31/506
[2024/27]
CPC:
A61K31/145 (EP,IL); A61K31/325 (US); A61K31/165 (EP,IL);
A61K31/337 (EP,IL); A61K31/4427 (EP,IL); A61K31/47 (EP,IL);
A61K31/506 (EP,IL); A61K31/5377 (EP,IL); A61K31/555 (EP,IL);
A61K31/7068 (EP,IL); A61K33/34 (EP,IL); A61K45/06 (EP,IL);
A61P35/00 (EP,IL,US); G01N33/5011 (EP,IL); G01N33/5079 (EP,IL,US);
G01N2800/52 (EP,IL) (-)
C-Set:
A61K31/145, A61K2300/00 (EP);
A61K31/165, A61K2300/00 (EP);
A61K31/337, A61K2300/00 (EP);
A61K31/4427, A61K2300/00 (EP);
A61K31/44, A61K2300/00 (EP);
A61K31/47, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP);
A61K31/5377, A61K2300/00 (EP);
A61K31/7068, A61K2300/00 (EP);
A61K33/34, A61K2300/00 (EP)
(-)
Former IPC [2023/01]G01N33/574, A61K31/30, A61K31/7135
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/01]
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON KREBS[2023/01]
English:METHODS OF TREATING CANCER[2023/01]
French:MÉTHODES DE TRAITEMENT DU CANCER[2023/01]
Entry into regional phase21.09.2022National basic fee paid 
21.09.2022Search fee paid 
21.09.2022Designation fee(s) paid 
21.09.2022Examination fee paid 
Examination procedure21.09.2022Examination requested  [2023/01]
12.04.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
21.09.2022Renewal fee patent year 03
27.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]US2018353445  (TSVETKOV PETER [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.